Tag: IDEAL trial

Increased risk of stillbirth recurrence after a previous stillbirth

Seladelpar (Livdelzi) raises the bar for primary biliary cholangitis treatment

byDeepti Shroff

June 9, 2026

1. Gilead reported positive phase 3 IDEAL data for seladelpar (Livdelzi) in patients with primary biliary cholangitis who had persistent ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Active surveillance is cost-effective compared with standard surgery among esophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy
Intraarterial dexamethasone may be effective for pain relief following uterine fibroid embolization
Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

No Result

View All Result